

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 6.21730477 |
| 2 | mammary gland epithelial cell proliferation (GO:0033598) | 5.83234351 |
| 3 | skin morphogenesis (GO:0043589) | 5.29735064 |
| 4 | substrate-dependent cell migration (GO:0006929) | 5.28963200 |
| 5 | cell adhesion mediated by integrin (GO:0033627) | 5.22299182 |
| 6 | vagina development (GO:0060068) | 5.20776317 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.13717988 |
| 8 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 5.07962861 |
| 9 | positive regulation of astrocyte differentiation (GO:0048711) | 5.03048321 |
| 10 | mesodermal cell differentiation (GO:0048333) | 4.99395589 |
| 11 | chondrocyte proliferation (GO:0035988) | 4.81960646 |
| 12 | uterus development (GO:0060065) | 4.67743780 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.66817110 |
| 14 | endodermal cell differentiation (GO:0035987) | 4.60300134 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.51203452 |
| 16 | protein localization to endosome (GO:0036010) | 4.45301709 |
| 17 | lung vasculature development (GO:0060426) | 4.42916000 |
| 18 | muscle cell migration (GO:0014812) | 4.41750660 |
| 19 | atrioventricular valve morphogenesis (GO:0003181) | 4.37736879 |
| 20 | female genitalia development (GO:0030540) | 4.35387808 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 4.22639515 |
| 22 | protein retention in ER lumen (GO:0006621) | 4.15883534 |
| 23 | hypotonic response (GO:0006971) | 4.15544504 |
| 24 | vocalization behavior (GO:0071625) | 4.12369163 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.05886383 |
| 26 | regulation of synapse structural plasticity (GO:0051823) | 4.04916391 |
| 27 | lung lobe morphogenesis (GO:0060463) | 4.01564436 |
| 28 | protein heterotrimerization (GO:0070208) | 4.01264559 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.96890478 |
| 30 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.92711688 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.92075508 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.91662204 |
| 33 | regulation of response to osmotic stress (GO:0047484) | 3.90487414 |
| 34 | COPI coating of Golgi vesicle (GO:0048205) | 3.86624121 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 3.86624121 |
| 36 | synaptic vesicle exocytosis (GO:0016079) | 3.86488751 |
| 37 | desmosome organization (GO:0002934) | 3.85153986 |
| 38 | mammary gland alveolus development (GO:0060749) | 3.84551244 |
| 39 | glutamate secretion (GO:0014047) | 3.82877625 |
| 40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.82307957 |
| 41 | cerebellar Purkinje cell layer development (GO:0021680) | 3.80191680 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.75874516 |
| 43 | activation of protein kinase A activity (GO:0034199) | 3.71085439 |
| 44 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.71049170 |
| 45 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.71049170 |
| 46 | branch elongation of an epithelium (GO:0060602) | 3.69220721 |
| 47 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.66563077 |
| 48 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.59587683 |
| 49 | plasma membrane repair (GO:0001778) | 3.56325672 |
| 50 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.56272285 |
| 51 | regulation of protein heterodimerization activity (GO:0043497) | 3.53339829 |
| 52 | protein maturation by protein folding (GO:0022417) | 3.49804543 |
| 53 | decidualization (GO:0046697) | 3.49009388 |
| 54 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.47056239 |
| 55 | neurotransmitter secretion (GO:0007269) | 3.44423055 |
| 56 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.43839047 |
| 57 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.41937539 |
| 58 | cell migration in hindbrain (GO:0021535) | 3.41714317 |
| 59 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.41127509 |
| 60 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.34412890 |
| 61 | protein localization to synapse (GO:0035418) | 3.33661809 |
| 62 | dendritic spine morphogenesis (GO:0060997) | 3.33622220 |
| 63 | regulation of early endosome to late endosome transport (GO:2000641) | 3.32223264 |
| 64 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.31983767 |
| 65 | negative regulation of microtubule polymerization (GO:0031115) | 3.30757123 |
| 66 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.30161618 |
| 67 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.29601753 |
| 68 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.27207828 |
| 69 | exploration behavior (GO:0035640) | 3.27180505 |
| 70 | basement membrane organization (GO:0071711) | 3.26469690 |
| 71 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.26408203 |
| 72 | positive regulation of synapse maturation (GO:0090129) | 3.25326447 |
| 73 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.24592344 |
| 74 | * regulation of neuronal synaptic plasticity (GO:0048168) | 3.24263213 |
| 75 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.22554628 |
| 76 | viral transcription (GO:0019083) | 3.22120245 |
| 77 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.21918611 |
| 78 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.18877103 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 3.18736838 |
| 80 | type B pancreatic cell proliferation (GO:0044342) | 3.16509245 |
| 81 | hair cycle (GO:0042633) | 3.15212003 |
| 82 | molting cycle (GO:0042303) | 3.15212003 |
| 83 | sodium ion export (GO:0071436) | 3.12764943 |
| 84 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.12705540 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11970667 |
| 86 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.11927182 |
| 87 | axon extension (GO:0048675) | 3.11707959 |
| 88 | muscle organ morphogenesis (GO:0048644) | 3.11334852 |
| 89 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.09727854 |
| 90 | translational termination (GO:0006415) | 3.08433487 |
| 91 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.07846975 |
| 92 | trophoblast giant cell differentiation (GO:0060707) | 3.07749853 |
| 93 | cell communication involved in cardiac conduction (GO:0086065) | 3.07747323 |
| 94 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.06785212 |
| 95 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 3.05947900 |
| 96 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.04394154 |
| 97 | cell communication by electrical coupling (GO:0010644) | 3.02892979 |
| 98 | axis elongation (GO:0003401) | 3.01808224 |
| 99 | virion attachment to host cell (GO:0019062) | 3.01773747 |
| 100 | adhesion of symbiont to host cell (GO:0044650) | 3.01773747 |
| 101 | positive regulation of axon extension (GO:0045773) | 2.97619115 |
| 102 | fibrinolysis (GO:0042730) | 2.97268919 |
| 103 | hemidesmosome assembly (GO:0031581) | 2.97083890 |
| 104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96359947 |
| 105 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.95901494 |
| 106 | collagen catabolic process (GO:0030574) | 2.95455716 |
| 107 | collagen metabolic process (GO:0032963) | 2.95014928 |
| 108 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.92610314 |
| 109 | establishment of monopolar cell polarity (GO:0061162) | 2.92610314 |
| 110 | prepulse inhibition (GO:0060134) | 2.91037034 |
| 111 | long-term memory (GO:0007616) | 2.90871843 |
| 112 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.90224194 |
| 113 | neuromuscular process controlling posture (GO:0050884) | 2.88948676 |
| 114 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.88559655 |
| 115 | regulation of synaptic vesicle transport (GO:1902803) | 2.88216718 |
| 116 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.87253099 |
| 117 | SMAD protein complex assembly (GO:0007183) | 2.86853757 |
| 118 | establishment of apical/basal cell polarity (GO:0035089) | 2.85993986 |
| 119 | adherens junction assembly (GO:0034333) | 2.82768055 |
| 120 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.81788681 |
| 121 | positive regulation of fibroblast migration (GO:0010763) | 2.80829216 |
| 122 | cellular response to vitamin D (GO:0071305) | 2.79845915 |
| 123 | negative regulation of cell size (GO:0045792) | 2.79171958 |
| 124 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.77082527 |
| 125 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.75255572 |
| 126 | adhesion of symbiont to host (GO:0044406) | 2.73602210 |
| 127 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.73582947 |
| 128 | positive regulation of vesicle fusion (GO:0031340) | 2.73273631 |
| 129 | dopamine receptor signaling pathway (GO:0007212) | 2.72255649 |
| 130 | translational elongation (GO:0006414) | 2.71563385 |
| 131 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71282923 |
| 132 | neuron projection extension (GO:1990138) | 2.70904293 |
| 133 | bone trabecula formation (GO:0060346) | 2.69603270 |
| 134 | stress fiber assembly (GO:0043149) | 2.69170233 |
| 135 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.67933838 |
| 136 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.66845859 |
| 137 | short-term memory (GO:0007614) | 2.66028621 |
| 138 | ephrin receptor signaling pathway (GO:0048013) | 2.65216951 |
| 139 | gamma-aminobutyric acid transport (GO:0015812) | 2.64519373 |
| 140 | maternal placenta development (GO:0001893) | 2.64516619 |
| 141 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.63462174 |
| 142 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.61692145 |
| 143 | multicellular organismal catabolic process (GO:0044243) | 2.61611363 |
| 144 | barbed-end actin filament capping (GO:0051016) | 2.60244337 |
| 145 | semaphorin-plexin signaling pathway (GO:0071526) | 2.59434764 |
| 146 | protein hydroxylation (GO:0018126) | 2.59228788 |
| 147 | positive regulation of membrane potential (GO:0045838) | 2.59150942 |
| 148 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.58592083 |
| 149 | N-glycan processing (GO:0006491) | 2.58494698 |
| 150 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.58240190 |
| 151 | cellular potassium ion homeostasis (GO:0030007) | 2.57447304 |
| 152 | regulation of smooth muscle cell migration (GO:0014910) | 2.57447116 |
| 153 | cellular protein complex disassembly (GO:0043624) | 2.56882754 |
| 154 | positive regulation of p38MAPK cascade (GO:1900745) | 2.56320414 |
| 155 | regulation of female receptivity (GO:0045924) | 2.56248751 |
| 156 | peptidyl-proline hydroxylation (GO:0019511) | 2.56216497 |
| 157 | regulation of protein kinase A signaling (GO:0010738) | 2.55342413 |
| 158 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.55279838 |
| 159 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.55241587 |
| 160 | behavioral fear response (GO:0001662) | 2.53406744 |
| 161 | behavioral defense response (GO:0002209) | 2.53406744 |
| 162 | proline transport (GO:0015824) | 2.53357246 |
| 163 | heterochromatin organization (GO:0070828) | 2.53273625 |
| 164 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.53242241 |
| 165 | positive regulation of osteoblast proliferation (GO:0033690) | 2.52672861 |
| 166 | positive regulation of monooxygenase activity (GO:0032770) | 2.52583694 |
| 167 | cellular response to vitamin (GO:0071295) | 2.52366495 |
| 168 | peptidyl-arginine methylation (GO:0018216) | 2.51937957 |
| 169 | peptidyl-arginine N-methylation (GO:0035246) | 2.51937957 |
| 170 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.51306816 |
| 171 | glial cell migration (GO:0008347) | 2.50912356 |
| 172 | * regulation of synaptic plasticity (GO:0048167) | 2.49172642 |
| 173 | regulation of dendritic spine development (GO:0060998) | 2.47131683 |
| 174 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.46388610 |
| 175 | synaptic transmission, dopaminergic (GO:0001963) | 2.45534156 |
| 176 | intermediate filament organization (GO:0045109) | 2.45504079 |
| 177 | cell-substrate adherens junction assembly (GO:0007045) | 2.41651034 |
| 178 | focal adhesion assembly (GO:0048041) | 2.41651034 |
| 179 | neurotransmitter transport (GO:0006836) | 2.41544818 |
| 180 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.41438692 |
| 181 | regulation of neurotransmitter levels (GO:0001505) | 2.40607832 |
| 182 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.40035568 |
| 183 | neuronal ion channel clustering (GO:0045161) | 2.39067848 |
| 184 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.38802947 |
| 185 | dendritic spine organization (GO:0097061) | 2.37739552 |
| 186 | mating behavior (GO:0007617) | 2.37650126 |
| 187 | keratinization (GO:0031424) | 2.36465632 |
| 188 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.35741251 |
| 189 | neuromuscular process (GO:0050905) | 2.35486310 |
| 190 | behavioral response to cocaine (GO:0048148) | 2.35115523 |
| 191 | cell-substrate junction assembly (GO:0007044) | 2.34378704 |
| 192 | auditory behavior (GO:0031223) | 2.33828779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.02576990 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.44039213 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.87914629 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.80529932 |
| 5 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.67553429 |
| 6 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.65629809 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.63680415 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.56325014 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.52122843 |
| 10 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.51314296 |
| 11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.42636404 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.39870157 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.32952561 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05366523 |
| 15 | KDM2B_26808549_Chip-Seq_K562_Human | 1.99001504 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96890596 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96890596 |
| 18 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.96709538 |
| 19 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.93944775 |
| 20 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.93346403 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92858299 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.92083936 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91746912 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91443939 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.90986947 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88195776 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84247217 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80084968 |
| 29 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79397914 |
| 30 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.78877226 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74158442 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73464742 |
| 33 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.72704785 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72577686 |
| 35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72030740 |
| 36 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.66481142 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65859443 |
| 38 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.65761706 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.64493741 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63398081 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.63328790 |
| 42 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.62939276 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.61404757 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60509054 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56787828 |
| 46 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.56522719 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.56447920 |
| 48 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54470785 |
| 49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.54173630 |
| 50 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.54087312 |
| 51 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.52735869 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52075317 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47287419 |
| 54 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45975395 |
| 55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45225572 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41543534 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41303955 |
| 58 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39986123 |
| 59 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38269644 |
| 60 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38263546 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37706326 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.36841006 |
| 63 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.36710925 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34351905 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33369482 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32261865 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32261262 |
| 68 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.32248634 |
| 69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31788966 |
| 70 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31777326 |
| 71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31365000 |
| 72 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31120221 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31039795 |
| 74 | * P68_20966046_ChIP-Seq_HELA_Human | 1.30547025 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30094295 |
| 76 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.29171702 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.28831183 |
| 78 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28693749 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.28439469 |
| 80 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27918671 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26732449 |
| 82 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.26289773 |
| 83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.26217541 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25268375 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25000074 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24465098 |
| 87 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23297901 |
| 88 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.22396813 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21895201 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21184585 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21107624 |
| 92 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20951130 |
| 93 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19070026 |
| 94 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.18605251 |
| 95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18064125 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16920979 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15717653 |
| 98 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14774662 |
| 99 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14498878 |
| 100 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14279515 |
| 101 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13167336 |
| 102 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.12917407 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12703014 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11376136 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10724808 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10479021 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08225453 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07086861 |
| 109 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.06855504 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06803777 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06032124 |
| 112 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05876055 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05856979 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05022263 |
| 115 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.04401230 |
| 116 | MYC_22102868_ChIP-Seq_BL_Human | 1.04011593 |
| 117 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03451970 |
| 118 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.03068653 |
| 119 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02566553 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01665591 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.01652597 |
| 122 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00502119 |
| 123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00367839 |
| 124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00097474 |
| 125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00097474 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99967140 |
| 127 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98984732 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98432498 |
| 129 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.98215842 |
| 130 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97852276 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97660046 |
| 132 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95648005 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95411863 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94819820 |
| 135 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94608780 |
| 136 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94564283 |
| 137 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94204390 |
| 138 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94012324 |
| 139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93579826 |
| 140 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.91284540 |
| 141 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.91279489 |
| 142 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88978356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.53616605 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.85591283 |
| 3 | MP0002822_catalepsy | 3.46354209 |
| 4 | MP0001542_abnormal_bone_strength | 3.34818041 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.31642494 |
| 6 | MP0002796_impaired_skin_barrier | 3.14053516 |
| 7 | MP0004270_analgesia | 3.04338321 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.98685082 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.86102245 |
| 10 | MP0003880_abnormal_central_pattern | 2.73997769 |
| 11 | MP0001727_abnormal_embryo_implantation | 2.61584575 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.36230218 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.35469619 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.31219536 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.28615410 |
| 16 | MP0000751_myopathy | 2.26333975 |
| 17 | MP0004272_abnormal_basement_membrane | 2.26223156 |
| 18 | MP0004858_abnormal_nervous_system | 2.25253749 |
| 19 | MP0003279_aneurysm | 2.23587414 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.21616774 |
| 21 | MP0009379_abnormal_foot_pigmentation | 2.20654166 |
| 22 | MP0005451_abnormal_body_composition | 2.16398225 |
| 23 | MP0009745_abnormal_behavioral_response | 2.15557995 |
| 24 | MP0005275_abnormal_skin_tensile | 2.10190125 |
| 25 | MP0002064_seizures | 1.87595349 |
| 26 | MP0000579_abnormal_nail_morphology | 1.87535253 |
| 27 | MP0010307_abnormal_tumor_latency | 1.86116377 |
| 28 | MP0001299_abnormal_eye_distance/ | 1.85135870 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.84896656 |
| 30 | MP0003329_amyloid_beta_deposits | 1.84284080 |
| 31 | MP0005501_abnormal_skin_physiology | 1.82033707 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.78419422 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.76898868 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.64816133 |
| 35 | MP0002736_abnormal_nociception_after | 1.64815119 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.62994017 |
| 37 | MP0003315_abnormal_perineum_morphology | 1.60166036 |
| 38 | MP0003941_abnormal_skin_development | 1.59931705 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.56610424 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.53089550 |
| 41 | MP0004510_myositis | 1.51100795 |
| 42 | MP0001970_abnormal_pain_threshold | 1.50201591 |
| 43 | MP0002896_abnormal_bone_mineralization | 1.48144739 |
| 44 | MP0003091_abnormal_cell_migration | 1.47345344 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.46256366 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.46186104 |
| 47 | MP0000747_muscle_weakness | 1.44676246 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.44451391 |
| 49 | MP0003123_paternal_imprinting | 1.43046869 |
| 50 | MP0002089_abnormal_postnatal_growth/wei | 1.40099617 |
| 51 | MP0009840_abnormal_foam_cell | 1.39648532 |
| 52 | MP0009053_abnormal_anal_canal | 1.39382389 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.39254224 |
| 54 | MP0009046_muscle_twitch | 1.39133286 |
| 55 | MP0000858_altered_metastatic_potential | 1.35721613 |
| 56 | MP0002177_abnormal_outer_ear | 1.35093416 |
| 57 | MP0010030_abnormal_orbit_morphology | 1.34437432 |
| 58 | MP0002295_abnormal_pulmonary_circulatio | 1.34000276 |
| 59 | MP0000733_abnormal_muscle_development | 1.33828795 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.33163377 |
| 61 | MP0000627_abnormal_mammary_gland | 1.31990009 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.28396375 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.28006198 |
| 64 | MP0010771_integument_phenotype | 1.27505252 |
| 65 | MP0008995_early_reproductive_senescence | 1.24737941 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.24613524 |
| 67 | MP0002160_abnormal_reproductive_system | 1.23420829 |
| 68 | MP0005023_abnormal_wound_healing | 1.23403493 |
| 69 | MP0000750_abnormal_muscle_regeneration | 1.23396785 |
| 70 | MP0002272_abnormal_nervous_system | 1.22909580 |
| 71 | MP0002184_abnormal_innervation | 1.20063760 |
| 72 | MP0001958_emphysema | 1.19659212 |
| 73 | MP0002060_abnormal_skin_morphology | 1.19597967 |
| 74 | MP0002234_abnormal_pharynx_morphology | 1.18831503 |
| 75 | MP0000955_abnormal_spinal_cord | 1.18211124 |
| 76 | MP0000749_muscle_degeneration | 1.16641238 |
| 77 | MP0003303_peritoneal_inflammation | 1.15294458 |
| 78 | MP0003646_muscle_fatigue | 1.13617329 |
| 79 | MP0001881_abnormal_mammary_gland | 1.13169455 |
| 80 | MP0000759_abnormal_skeletal_muscle | 1.12511343 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.11167071 |
| 82 | MP0000467_abnormal_esophagus_morphology | 1.09339894 |
| 83 | MP0003879_abnormal_hair_cell | 1.08963152 |
| 84 | MP0001849_ear_inflammation | 1.08614053 |
| 85 | MP0004087_abnormal_muscle_fiber | 1.07335235 |
| 86 | MP0005166_decreased_susceptibility_to | 1.06844325 |
| 87 | MP0005197_abnormal_uvea_morphology | 1.05916773 |
| 88 | MP0004130_abnormal_muscle_cell | 1.04911226 |
| 89 | MP0001905_abnormal_dopamine_level | 1.04610294 |
| 90 | MP0000537_abnormal_urethra_morphology | 1.03356893 |
| 91 | MP0009250_abnormal_appendicular_skeleto | 1.02871197 |
| 92 | MP0005330_cardiomyopathy | 1.02709094 |
| 93 | MP0005164_abnormal_response_to | 1.01094668 |
| 94 | MP0005508_abnormal_skeleton_morphology | 1.00852365 |
| 95 | MP0008569_lethality_at_weaning | 0.99915510 |
| 96 | MP0001486_abnormal_startle_reflex | 0.99490174 |
| 97 | MP0002269_muscular_atrophy | 0.99338528 |
| 98 | MP0005083_abnormal_biliary_tract | 0.98517985 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.97699272 |
| 100 | MP0003385_abnormal_body_wall | 0.97649621 |
| 101 | MP0009672_abnormal_birth_weight | 0.97298492 |
| 102 | MP0002557_abnormal_social/conspecific_i | 0.96438044 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 0.95881133 |
| 104 | MP0008874_decreased_physiological_sensi | 0.94249791 |
| 105 | MP0005423_abnormal_somatic_nervous | 0.94128522 |
| 106 | MP0005360_urolithiasis | 0.94089178 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.93186137 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.91822197 |
| 109 | MP0003075_altered_response_to | 0.91164433 |
| 110 | MP0000778_abnormal_nervous_system | 0.90819587 |
| 111 | MP0003786_premature_aging | 0.90615559 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.90152329 |
| 113 | MP0003283_abnormal_digestive_organ | 0.89151699 |
| 114 | MP0000013_abnormal_adipose_tissue | 0.88787463 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.87569179 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.86850989 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.86731736 |
| 118 | MP0003942_abnormal_urinary_system | 0.84689954 |
| 119 | MP0001919_abnormal_reproductive_system | 0.84323517 |
| 120 | MP0002882_abnormal_neuron_morphology | 0.83948872 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.82418327 |
| 122 | MP0010352_gastrointestinal_tract_polyps | 0.81869442 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.81460039 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.80866856 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.79968413 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.79910095 |
| 127 | MP0002139_abnormal_hepatobiliary_system | 0.79592640 |
| 128 | MP0003119_abnormal_digestive_system | 0.79291598 |
| 129 | MP0003936_abnormal_reproductive_system | 0.78711457 |
| 130 | MP0003634_abnormal_glial_cell | 0.78664959 |
| 131 | MP0005085_abnormal_gallbladder_physiolo | 0.78059810 |
| 132 | MP0004085_abnormal_heartbeat | 0.77808775 |
| 133 | MP0005595_abnormal_vascular_smooth | 0.77611650 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.77103013 |
| 135 | MP0000678_abnormal_parathyroid_gland | 0.76404109 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.75689488 |
| 137 | MP0005620_abnormal_muscle_contractility | 0.74740228 |
| 138 | MP0004924_abnormal_behavior | 0.74046335 |
| 139 | MP0005386_behavior/neurological_phenoty | 0.74046335 |
| 140 | MP0002108_abnormal_muscle_morphology | 0.73964533 |
| 141 | MP0008770_decreased_survivor_rate | 0.73926475 |
| 142 | MP0004233_abnormal_muscle_weight | 0.73620252 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.73004830 |
| 144 | MP0005390_skeleton_phenotype | 0.71825707 |
| 145 | MP0003448_altered_tumor_morphology | 0.71214533 |
| 146 | MP0005409_darkened_coat_color | 0.70829515 |
| 147 | MP0002152_abnormal_brain_morphology | 0.69959686 |
| 148 | MP0002972_abnormal_cardiac_muscle | 0.69935803 |
| 149 | MP0005375_adipose_tissue_phenotype | 0.69463883 |
| 150 | MP0006276_abnormal_autonomic_nervous | 0.69315504 |
| 151 | MP0002106_abnormal_muscle_physiology | 0.69191719 |
| 152 | MP0008872_abnormal_physiological_respon | 0.68009528 |
| 153 | MP0002254_reproductive_system_inflammat | 0.67017574 |
| 154 | MP0001216_abnormal_epidermal_layer | 0.66527693 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.66122987 |
| 156 | MP0003172_abnormal_lysosome_physiology | 0.65525049 |
| 157 | MP0001346_abnormal_lacrimal_gland | 0.64666824 |
| 158 | MP0005167_abnormal_blood-brain_barrier | 0.64114321 |
| 159 | MP0000647_abnormal_sebaceous_gland | 0.64012242 |
| 160 | MP0005187_abnormal_penis_morphology | 0.63573289 |
| 161 | MP0000604_amyloidosis | 0.63117583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Follicular hyperkeratosis (HP:0007502) | 6.11637883 |
| 2 | Myokymia (HP:0002411) | 5.97241416 |
| 3 | Ankle contracture (HP:0006466) | 5.58752674 |
| 4 | Slender build (HP:0001533) | 5.55673699 |
| 5 | Spinal rigidity (HP:0003306) | 4.84912807 |
| 6 | Hypoventilation (HP:0002791) | 3.81292174 |
| 7 | Focal motor seizures (HP:0011153) | 3.79290578 |
| 8 | * Achilles tendon contracture (HP:0001771) | 3.51288287 |
| 9 | Hyperacusis (HP:0010780) | 3.48644933 |
| 10 | Visual hallucinations (HP:0002367) | 3.47449554 |
| 11 | * Abnormality of the Achilles tendon (HP:0005109) | 3.38744389 |
| 12 | Generalized amyotrophy (HP:0003700) | 3.38231871 |
| 13 | Bladder diverticulum (HP:0000015) | 3.37123258 |
| 14 | Elbow flexion contracture (HP:0002987) | 3.13176163 |
| 15 | Focal seizures (HP:0007359) | 3.08742071 |
| 16 | Difficulty climbing stairs (HP:0003551) | 3.03661263 |
| 17 | Ventricular fibrillation (HP:0001663) | 3.03292785 |
| 18 | Abnormality of dentin (HP:0010299) | 2.92689150 |
| 19 | Testicular atrophy (HP:0000029) | 2.88181964 |
| 20 | Long palpebral fissure (HP:0000637) | 2.72377317 |
| 21 | Annular pancreas (HP:0001734) | 2.70135075 |
| 22 | Vertebral compression fractures (HP:0002953) | 2.70123408 |
| 23 | Myotonia (HP:0002486) | 2.68392906 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 2.65037366 |
| 25 | Exercise-induced myalgia (HP:0003738) | 2.64971869 |
| 26 | Aortic dissection (HP:0002647) | 2.64544935 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 2.63172887 |
| 28 | Renal duplication (HP:0000075) | 2.62139317 |
| 29 | Limb-girdle muscle weakness (HP:0003325) | 2.55533584 |
| 30 | Hypercortisolism (HP:0001578) | 2.54697267 |
| 31 | Hypotrichosis (HP:0001006) | 2.53427675 |
| 32 | Hand muscle atrophy (HP:0009130) | 2.53134939 |
| 33 | Depression (HP:0000716) | 2.53025246 |
| 34 | Lower limb amyotrophy (HP:0007210) | 2.51685959 |
| 35 | Soft skin (HP:0000977) | 2.47380134 |
| 36 | * Fragile nails (HP:0001808) | 2.47173854 |
| 37 | Abnormality of oral frenula (HP:0000190) | 2.46760968 |
| 38 | Blue sclerae (HP:0000592) | 2.45916910 |
| 39 | Vascular tortuosity (HP:0004948) | 2.44092099 |
| 40 | Increased connective tissue (HP:0009025) | 2.43636417 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.43385316 |
| 42 | Pili torti (HP:0003777) | 2.42721050 |
| 43 | * Genu recurvatum (HP:0002816) | 2.39834886 |
| 44 | Cervical subluxation (HP:0003308) | 2.39355358 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.38885188 |
| 46 | Delusions (HP:0000746) | 2.36505570 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.36326492 |
| 48 | Protruding ear (HP:0000411) | 2.34937597 |
| 49 | * Sudden death (HP:0001699) | 2.34380758 |
| 50 | Torticollis (HP:0000473) | 2.32861336 |
| 51 | Round ear (HP:0100830) | 2.32380766 |
| 52 | Arterial tortuosity (HP:0005116) | 2.31721728 |
| 53 | Protrusio acetabuli (HP:0003179) | 2.31250047 |
| 54 | Short nail (HP:0001799) | 2.29431160 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.26139706 |
| 56 | Anxiety (HP:0000739) | 2.25541665 |
| 57 | Deep venous thrombosis (HP:0002625) | 2.25286730 |
| 58 | Difficulty running (HP:0009046) | 2.24939762 |
| 59 | Long toe (HP:0010511) | 2.24877305 |
| 60 | Overriding aorta (HP:0002623) | 2.24635809 |
| 61 | Absence seizures (HP:0002121) | 2.24614254 |
| 62 | Myopathic facies (HP:0002058) | 2.24558867 |
| 63 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24256881 |
| 64 | Rapidly progressive (HP:0003678) | 2.23782322 |
| 65 | Amblyopia (HP:0000646) | 2.23088890 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.22722143 |
| 67 | Action tremor (HP:0002345) | 2.22343457 |
| 68 | Focal dystonia (HP:0004373) | 2.21903153 |
| 69 | Wormian bones (HP:0002645) | 2.21473852 |
| 70 | Distal arthrogryposis (HP:0005684) | 2.20882153 |
| 71 | Bowel diverticulosis (HP:0005222) | 2.20631343 |
| 72 | Truncus arteriosus (HP:0001660) | 2.20483744 |
| 73 | Hydroureter (HP:0000072) | 2.20200905 |
| 74 | Disproportionate tall stature (HP:0001519) | 2.17787168 |
| 75 | Mitral regurgitation (HP:0001653) | 2.17363407 |
| 76 | Craniofacial dystonia (HP:0012179) | 2.16526929 |
| 77 | Joint laxity (HP:0001388) | 2.16081646 |
| 78 | Resting tremor (HP:0002322) | 2.14963973 |
| 79 | Hyperextensible skin (HP:0000974) | 2.14305496 |
| 80 | Ankyloglossia (HP:0010296) | 2.13972007 |
| 81 | Elfin facies (HP:0004428) | 2.12104984 |
| 82 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.11527140 |
| 83 | Ulnar bowing (HP:0003031) | 2.10300684 |
| 84 | Abnormal social behavior (HP:0012433) | 2.10199919 |
| 85 | Impaired social interactions (HP:0000735) | 2.10199919 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.09777605 |
| 87 | Muscle fiber inclusion bodies (HP:0100299) | 2.09755163 |
| 88 | Hyperthyroidism (HP:0000836) | 2.09677607 |
| 89 | Conjunctival hamartoma (HP:0100780) | 2.07421378 |
| 90 | Type 1 muscle fiber predominance (HP:0003803) | 2.07416962 |
| 91 | Shoulder girdle muscle weakness (HP:0003547) | 2.07044682 |
| 92 | Exercise-induced muscle cramps (HP:0003710) | 2.05458643 |
| 93 | Onycholysis (HP:0001806) | 2.04655365 |
| 94 | Neonatal onset (HP:0003623) | 2.04606021 |
| 95 | Atrophic scars (HP:0001075) | 2.04129091 |
| 96 | Insomnia (HP:0100785) | 2.03987079 |
| 97 | Hallux valgus (HP:0001822) | 2.03974897 |
| 98 | Distal upper limb amyotrophy (HP:0007149) | 2.03918332 |
| 99 | Upper limb amyotrophy (HP:0009129) | 2.03918332 |
| 100 | Generalized tonic-clonic seizures (HP:0002069) | 2.03338131 |
| 101 | Milia (HP:0001056) | 2.03113029 |
| 102 | Congenital glaucoma (HP:0001087) | 2.00719858 |
| 103 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00471975 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 2.00441477 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00058046 |
| 106 | EMG: myopathic abnormalities (HP:0003458) | 1.99838008 |
| 107 | Poor eye contact (HP:0000817) | 1.99287996 |
| 108 | Cholecystitis (HP:0001082) | 1.98619872 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 1.98619872 |
| 110 | Syringomyelia (HP:0003396) | 1.98571196 |
| 111 | Spinal cord lesions (HP:0100561) | 1.98571196 |
| 112 | Fragile skin (HP:0001030) | 1.97821667 |
| 113 | Ankle clonus (HP:0011448) | 1.97421779 |
| 114 | Hyperparathyroidism (HP:0000843) | 1.97302335 |
| 115 | Premature skin wrinkling (HP:0100678) | 1.97171460 |
| 116 | Status epilepticus (HP:0002133) | 1.96438951 |
| 117 | Deviation of the hallux (HP:0010051) | 1.95559102 |
| 118 | Plantar hyperkeratosis (HP:0007556) | 1.93634057 |
| 119 | Nemaline bodies (HP:0003798) | 1.91199914 |
| 120 | Hypercalcemia (HP:0003072) | 1.91048478 |
| 121 | Dialeptic seizures (HP:0011146) | 1.91008473 |
| 122 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.90661228 |
| 123 | Progressive muscle weakness (HP:0003323) | 1.90543738 |
| 124 | Natal tooth (HP:0000695) | 1.90214818 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.90182894 |
| 126 | Muscle stiffness (HP:0003552) | 1.89317806 |
| 127 | Abnormal atrioventricular conduction (HP:0005150) | 1.88483079 |
| 128 | Mutism (HP:0002300) | 1.87362432 |
| 129 | Bundle branch block (HP:0011710) | 1.87344803 |
| 130 | Adducted thumb (HP:0001181) | 1.86957046 |
| 131 | Biconcave vertebral bodies (HP:0004586) | 1.86071013 |
| 132 | Aortic aneurysm (HP:0004942) | 1.85735523 |
| 133 | Abnormality of the calf musculature (HP:0001430) | 1.85368906 |
| 134 | Nail dystrophy (HP:0008404) | 1.84951626 |
| 135 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84753670 |
| 136 | Calf muscle hypertrophy (HP:0008981) | 1.84669609 |
| 137 | Abnormality of the umbilical cord (HP:0010881) | 1.80606310 |
| 138 | Ragged-red muscle fibers (HP:0003200) | 1.80124183 |
| 139 | Cardiovascular calcification (HP:0011915) | 1.78937350 |
| 140 | Atonic seizures (HP:0010819) | 1.78885799 |
| 141 | Urinary urgency (HP:0000012) | 1.78559446 |
| 142 | Trismus (HP:0000211) | 1.78322607 |
| 143 | Aplasia of the musculature (HP:0100854) | 1.76135518 |
| 144 | Dysdiadochokinesis (HP:0002075) | 1.76074009 |
| 145 | Hamartoma of the eye (HP:0010568) | 1.75474382 |
| 146 | Neonatal short-limb short stature (HP:0008921) | 1.74416474 |
| 147 | Gout (HP:0001997) | 1.74385010 |
| 148 | Short clavicles (HP:0000894) | 1.73280230 |
| 149 | * Woolly hair (HP:0002224) | 1.72472853 |
| 150 | Neurofibrillary tangles (HP:0002185) | 1.72217317 |
| 151 | * Osteopenia (HP:0000938) | 1.72052044 |
| 152 | Ventricular arrhythmia (HP:0004308) | 1.71244555 |
| 153 | Shallow orbits (HP:0000586) | 1.71236539 |
| 154 | Buphthalmos (HP:0000557) | 1.71187921 |
| 155 | Flat cornea (HP:0007720) | 1.70174817 |
| 156 | Pelvic girdle muscle weakness (HP:0003749) | 1.69939414 |
| 157 | Atrioventricular block (HP:0001678) | 1.69585633 |
| 158 | Muscle fiber splitting (HP:0003555) | 1.68657946 |
| 159 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.67549216 |
| 160 | Multiple lipomas (HP:0001012) | 1.66000093 |
| 161 | Malnutrition (HP:0004395) | 1.65528031 |
| 162 | Sparse lateral eyebrow (HP:0005338) | 1.65318857 |
| 163 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.64930620 |
| 164 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.64930620 |
| 165 | Single umbilical artery (HP:0001195) | 1.64930620 |
| 166 | Patellar dislocation (HP:0002999) | 1.62546794 |
| 167 | Vascular calcification (HP:0004934) | 1.62457967 |
| 168 | Stridor (HP:0010307) | 1.62006568 |
| 169 | Coxa vara (HP:0002812) | 1.60931013 |
| 170 | Joint stiffness (HP:0001387) | 1.60457186 |
| 171 | Ulnar deviation of the wrist (HP:0003049) | 1.60245367 |
| 172 | Renovascular hypertension (HP:0100817) | 1.58157621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.73281535 |
| 2 | IRAK3 | 3.69186401 |
| 3 | EPHA4 | 3.51800189 |
| 4 | TRIB3 | 3.35804151 |
| 5 | KSR2 | 2.79725382 |
| 6 | TLK1 | 2.71997137 |
| 7 | MINK1 | 2.37104691 |
| 8 | NTRK3 | 2.36535338 |
| 9 | LATS2 | 2.35343828 |
| 10 | SIK1 | 2.26622462 |
| 11 | DAPK2 | 2.26225609 |
| 12 | TAOK1 | 2.20910707 |
| 13 | RPS6KA2 | 2.20051762 |
| 14 | PKN2 | 2.15174734 |
| 15 | PRKD3 | 2.14597523 |
| 16 | GRK6 | 1.95465217 |
| 17 | PIM2 | 1.94293422 |
| 18 | MAP3K11 | 1.87479037 |
| 19 | GRK1 | 1.86802412 |
| 20 | NTRK1 | 1.76481068 |
| 21 | NEK1 | 1.74520143 |
| 22 | MARK1 | 1.71664328 |
| 23 | MYLK | 1.70389799 |
| 24 | FER | 1.67160457 |
| 25 | MAP3K2 | 1.64478135 |
| 26 | SCYL2 | 1.63888253 |
| 27 | DAPK3 | 1.61990636 |
| 28 | PAK6 | 1.61375075 |
| 29 | ADRBK2 | 1.58349877 |
| 30 | MAP2K4 | 1.53901489 |
| 31 | CAMKK1 | 1.52627369 |
| 32 | TAOK2 | 1.48438591 |
| 33 | PRPF4B | 1.45764838 |
| 34 | ARAF | 1.43615814 |
| 35 | MET | 1.42262487 |
| 36 | FLT3 | 1.41005484 |
| 37 | NME1 | 1.40100242 |
| 38 | GRK5 | 1.36328586 |
| 39 | PHKG2 | 1.35100492 |
| 40 | PHKG1 | 1.35100492 |
| 41 | STK38 | 1.33287054 |
| 42 | KSR1 | 1.32494549 |
| 43 | NME2 | 1.30111721 |
| 44 | EPHB2 | 1.30084190 |
| 45 | RPS6KC1 | 1.29083208 |
| 46 | RPS6KL1 | 1.29083208 |
| 47 | LIMK1 | 1.28707297 |
| 48 | DMPK | 1.27835059 |
| 49 | IKBKE | 1.26651229 |
| 50 | SMG1 | 1.24502799 |
| 51 | TYRO3 | 1.23636888 |
| 52 | MAP3K4 | 1.21883903 |
| 53 | ERBB4 | 1.18281140 |
| 54 | ILK | 1.17541113 |
| 55 | IRAK2 | 1.15781463 |
| 56 | TESK1 | 1.14936367 |
| 57 | CDK14 | 1.10959611 |
| 58 | CDK5 | 1.09623761 |
| 59 | AKT3 | 1.08268305 |
| 60 | TTN | 1.08168345 |
| 61 | ALK | 1.08144873 |
| 62 | RET | 1.06251099 |
| 63 | CDK7 | 1.05557798 |
| 64 | RIPK1 | 1.04338212 |
| 65 | CHUK | 1.04160080 |
| 66 | PAK1 | 1.03802217 |
| 67 | AKT2 | 1.03701887 |
| 68 | ERN1 | 1.03560750 |
| 69 | RPS6KA6 | 1.03554319 |
| 70 | MAP3K1 | 1.03210435 |
| 71 | LMTK2 | 1.02772588 |
| 72 | DAPK1 | 0.97771265 |
| 73 | PAK2 | 0.97749617 |
| 74 | CDK19 | 0.97432460 |
| 75 | CDK15 | 0.96604892 |
| 76 | TESK2 | 0.95902740 |
| 77 | BMX | 0.92359491 |
| 78 | UHMK1 | 0.91455517 |
| 79 | CDK18 | 0.90672122 |
| 80 | FES | 0.89474319 |
| 81 | CDK11A | 0.89307153 |
| 82 | EIF2AK1 | 0.84867199 |
| 83 | MAP3K12 | 0.84773931 |
| 84 | DDR2 | 0.83097499 |
| 85 | PTK2B | 0.82970914 |
| 86 | MTOR | 0.81579909 |
| 87 | STK11 | 0.81517175 |
| 88 | LRRK2 | 0.80377616 |
| 89 | MAP2K1 | 0.78600892 |
| 90 | MAPKAPK3 | 0.78376763 |
| 91 | NTRK2 | 0.74410078 |
| 92 | PDGFRA | 0.72489323 |
| 93 | SIK2 | 0.72354583 |
| 94 | MAPK4 | 0.72227428 |
| 95 | CDK8 | 0.72108262 |
| 96 | PRKCG | 0.70543317 |
| 97 | EEF2K | 0.70155671 |
| 98 | MAP3K13 | 0.69705765 |
| 99 | CDC42BPA | 0.69485077 |
| 100 | RIPK4 | 0.68477041 |
| 101 | ABL2 | 0.67802319 |
| 102 | RAF1 | 0.65915206 |
| 103 | PTK2 | 0.63479826 |
| 104 | EPHB1 | 0.62908269 |
| 105 | PDPK1 | 0.62262422 |
| 106 | ADRBK1 | 0.60475492 |
| 107 | PAK3 | 0.59105202 |
| 108 | MAP2K3 | 0.58312715 |
| 109 | PRKG2 | 0.56220687 |
| 110 | MAPKAPK2 | 0.54212237 |
| 111 | AURKA | 0.54094389 |
| 112 | PDGFRB | 0.50503600 |
| 113 | EPHA2 | 0.48476367 |
| 114 | CAMK2A | 0.47705418 |
| 115 | PRKCZ | 0.47356781 |
| 116 | MAP2K7 | 0.47004350 |
| 117 | PAK4 | 0.46841332 |
| 118 | TGFBR2 | 0.46574175 |
| 119 | BCKDK | 0.45492836 |
| 120 | MOS | 0.45080155 |
| 121 | PRKD2 | 0.44934757 |
| 122 | ICK | 0.44251508 |
| 123 | ROCK1 | 0.42624416 |
| 124 | PRKD1 | 0.42622320 |
| 125 | BRAF | 0.41931966 |
| 126 | CAMK2G | 0.41519620 |
| 127 | DYRK1B | 0.40904060 |
| 128 | MARK2 | 0.40763875 |
| 129 | MAP3K3 | 0.40569944 |
| 130 | CAMK1 | 0.40509219 |
| 131 | PRKCI | 0.40350892 |
| 132 | PDK1 | 0.40148062 |
| 133 | ZAP70 | 0.39847964 |
| 134 | MAP3K8 | 0.39375931 |
| 135 | PDK4 | 0.38249681 |
| 136 | PDK3 | 0.38249681 |
| 137 | MST1R | 0.38004966 |
| 138 | MAP2K2 | 0.37636896 |
| 139 | CSNK1E | 0.37591418 |
| 140 | STK16 | 0.37185259 |
| 141 | MAP3K6 | 0.36860165 |
| 142 | MAP3K5 | 0.36345990 |
| 143 | RPS6KB1 | 0.35999287 |
| 144 | ROCK2 | 0.35772352 |
| 145 | PTK6 | 0.35506213 |
| 146 | BRSK1 | 0.35255617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.32747878 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.69088254 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.67947619 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.59364480 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.34262351 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34248600 |
| 7 | * Focal adhesion_Homo sapiens_hsa04510 | 2.29469156 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18069994 |
| 9 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.10674891 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.98921724 |
| 11 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.89800260 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.84775217 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.84647138 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.83154537 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77769535 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68490946 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68389127 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.66426378 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66128994 |
| 20 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.64819472 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61279320 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.60844552 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59226545 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.57795632 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.57680734 |
| 26 | * Gap junction_Homo sapiens_hsa04540 | 1.54918618 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54072428 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47785259 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.47696334 |
| 30 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46686475 |
| 31 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.44115610 |
| 32 | * Glioma_Homo sapiens_hsa05214 | 1.43590438 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43535520 |
| 34 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43061258 |
| 35 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41161247 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40178294 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.38896260 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.37688113 |
| 39 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.37267079 |
| 40 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.37036094 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34411236 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33880447 |
| 43 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.28423602 |
| 44 | * Melanogenesis_Homo sapiens_hsa04916 | 1.26279358 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.26088000 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.25403714 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.24645986 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24510688 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21293052 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.20943303 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20493577 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20304673 |
| 53 | * Bladder cancer_Homo sapiens_hsa05219 | 1.19169941 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16544595 |
| 55 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15979971 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14710105 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 1.12061377 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10520629 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10055191 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.09465021 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.08357889 |
| 62 | * Long-term depression_Homo sapiens_hsa04730 | 1.06422239 |
| 63 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05688042 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 1.03474334 |
| 65 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02366774 |
| 66 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00690300 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00379003 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99254292 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98758544 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97214790 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96572550 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96021304 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95662504 |
| 74 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.94533256 |
| 75 | * Melanoma_Homo sapiens_hsa05218 | 0.94247365 |
| 76 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.93827836 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93567552 |
| 78 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92464247 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90477055 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90421379 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88154894 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.86107098 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85879594 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85595535 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84926067 |
| 86 | * Axon guidance_Homo sapiens_hsa04360 | 0.83439312 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.82816758 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82405200 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81589859 |
| 90 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.80154791 |
| 91 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80112205 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79964512 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79237103 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79110767 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78401462 |
| 96 | * Tight junction_Homo sapiens_hsa04530 | 0.76045036 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75784099 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.74562832 |
| 99 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74515766 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73834068 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72873687 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70528790 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69766191 |
| 104 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65861149 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64043062 |
| 106 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63475635 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.63324612 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60912812 |
| 109 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60572177 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60128950 |
| 111 | Taste transduction_Homo sapiens_hsa04742 | 0.60103479 |
| 112 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59816008 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59808333 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57541509 |
| 115 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.56256796 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.55866225 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55819179 |
| 118 | * Apoptosis_Homo sapiens_hsa04210 | 0.55484208 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54014855 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53659074 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52870006 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52194386 |
| 123 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52062493 |
| 124 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51956259 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51491345 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51383570 |
| 127 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51033558 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50937713 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50200965 |
| 130 | * Endocytosis_Homo sapiens_hsa04144 | 0.49827219 |
| 131 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49755944 |
| 132 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48987772 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48962631 |
| 134 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.48643666 |
| 135 | * Alcoholism_Homo sapiens_hsa05034 | 0.46887893 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46177246 |
| 137 | Adherens junction_Homo sapiens_hsa04520 | 0.45583927 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45129908 |
| 139 | * Serotonergic synapse_Homo sapiens_hsa04726 | 0.44926682 |
| 140 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44848504 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44508255 |
| 142 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42628137 |
| 143 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42602251 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42293698 |
| 145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42245481 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | 0.42010650 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39677230 |
| 148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37118938 |

